Plain-English translation of NCT06828640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using vaginal dilators—medical devices that come in gradually larger sizes—along with standard treatments can help relieve menopausal vaginal dryness, irritation, and pain during sex. Some women will receive standard care alone (hormonal therapy, lubricants, and moisturizers), while others will also use the vaginal dilators over 12 weeks. The goal is to see if this treatment approach works better than standard care by itself.
Many women experience vaginal dryness, thinning, and discomfort during and after menopause—and breast cancer survivors often face even worse symptoms. Doctors want to know if adding a simple physical device to current treatments can help more women feel better and improve their quality of life and sexual health.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the standard treatment group or the standard treatment plus vaginal dilators group. Both groups will continue their usual care (hormonal therapy, lubricants, and moisturizers if prescribed). If you're in the dilator group, you'll use a set of medical-grade silicone dilators that gradually increase in size, following your doctor's instructions. You'll have check-in visits at 4 weeks and 12 weeks, where doctors will ask about your symptoms, examine you, and ask questions about vaginal dryness, irritation, itching, and sexual function to see how well the treatment is working.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Belgium